We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Refrigerated Stem Cells Survive 12 Times Longer with ProtoKinetix’s AAGP™
News

Refrigerated Stem Cells Survive 12 Times Longer with ProtoKinetix’s AAGP™

Refrigerated Stem Cells Survive 12 Times Longer with ProtoKinetix’s AAGP™
News

Refrigerated Stem Cells Survive 12 Times Longer with ProtoKinetix’s AAGP™

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Refrigerated Stem Cells Survive 12 Times Longer with ProtoKinetix’s AAGP™"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

As a follow up to ProtoKinetix Inc.’s May 23, 2007 press release related to cryopreserved (or frozen) cells treated with AAGP™, in collaboration with the University of Helsinki, Finland, ProtoKinetix has recently finished a set of trials designed to determine whether AAGP™ treated cells could survive after preservation in refrigeration (4°C).

Commenting on the results, ProtoKinetix’s Director of Scientific Affairs, Dr. John Todd, stated, “After 3 days of preservation in refrigeration, untreated stem cells have a very high mortality rate. In the most recent experiments with the University of Helsinki, Finland, it was determined that AAGP™ can significantly reduce this cell death rate. AAGP™ demonstrated an impressive and repetitive 8 to 12 times increase in cell viability and survivability.”

Dr. Todd added, “These results are extremely important and encouraging for isolating the limited stem cell populations found in certain organs and tissues, such as umbilical cord blood and bone marrow. The implications for the treatment of certain types of cancers, such as leukemia and other conditions requiring bone marrow transplant are enormous.”

Advertisement